arrow
O

Obdulia Rabal

centro de investigacion medica aplicada
H指数:32
被引数:3,479

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
2024-07-022
OAAI
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma
2021-03-0416
PREAI
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles
2019-08-2335
PREAI
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
2019-07-03138
PREAI
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
2019-04-0124
PREAI
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma
2019-01-0486
OAAI
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors

用于治疗阿尔茨海默病的体内化学探针的发现: 双重磷酸二酯酶5 (PDE5) 和I类组蛋白脱乙酰酶选择性抑制剂

2018-12-1034
PREAI
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
2018-06-2842
PREAI
Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
2018-04-0162
PREAI